These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 26338721)

  • 1. Diabetes mellitus and gynecologic cancer: molecular mechanisms, epidemiological, clinical and prognostic perspectives.
    Vrachnis N; Iavazzo C; Iliodromiti Z; Sifakis S; Alexandrou A; Siristatidis C; Grigoriadis C; Botsis D; Creatsas G
    Arch Gynecol Obstet; 2016 Feb; 293(2):239-46. PubMed ID: 26338721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes mellitus and the risk of cancer.
    Pandey A; Forte V; Abdallah M; Alickaj A; Mahmud S; Asad S; McFarlane SI
    Minerva Endocrinol; 2011 Sep; 36(3):187-209. PubMed ID: 22019750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diabetes and cancer risk: oncologic considerations].
    Rosta A
    Orv Hetil; 2011 Jul; 152(29):1144-55. PubMed ID: 21712179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management.
    Singh MK; Das BK; Choudhary S; Gupta D; Patil UK
    Biomed Pharmacother; 2018 Oct; 106():991-1002. PubMed ID: 30119271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linking type 2 diabetes and gynecological cancer: an introductory overview.
    Anastasi E; Filardi T; Tartaglione S; Lenzi A; Angeloni A; Morano S
    Clin Chem Lab Med; 2018 Aug; 56(9):1413-1425. PubMed ID: 29427549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New clinical data with metformin therapy in patients with diabetes mellitus].
    Jermendy G
    Orv Hetil; 2010 Dec; 151(49):2025-30. PubMed ID: 21106483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting insulin analogs and cancer.
    Sciacca L; Vella V; Frittitta L; Tumminia A; Manzella L; Squatrito S; Belfiore A; Vigneri R
    Nutr Metab Cardiovasc Dis; 2018 May; 28(5):436-443. PubMed ID: 29609864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of malignancies in patients with diabetes mellitus and correlation with treatment modalities in a large Israeli health maintenance organization: a historical cohort study.
    Buchs AE; Silverman BG
    Metabolism; 2011 Oct; 60(10):1379-85. PubMed ID: 21696791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular action of insulin-sensitizing agents].
    Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
    Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and cancer.
    Chowdhury TA
    QJM; 2010 Dec; 103(12):905-15. PubMed ID: 20739356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes and ovarian cancer: risk factors, molecular mechanisms and impact on prognosis.
    Karimi F; Dinarvand N; Sabaghan M; Azadbakht O; Ataee S; Kharazinejad E; Moazamfard M
    Endocrine; 2024 Jan; 83(1):1-9. PubMed ID: 37552417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes and Cancer: a Review of Current Knowledge.
    Wojciechowska J; Krajewski W; Bolanowski M; Kręcicki T; Zatoński T
    Exp Clin Endocrinol Diabetes; 2016 May; 124(5):263-75. PubMed ID: 27219686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diabetes and cancer: an injurious association].
    Gariani K; Tran C; Philippe J
    Rev Med Suisse; 2010 Jun; 6(252):1193-4, 1196-8. PubMed ID: 20614754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
    Tseng CH
    Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.
    Sciacca L; Vigneri R; Tumminia A; Frasca F; Squatrito S; Frittitta L; Vigneri P
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):808-15. PubMed ID: 23932729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes, cancer, and metformin: connections of metabolism and cell proliferation.
    Gallagher EJ; LeRoith D
    Ann N Y Acad Sci; 2011 Dec; 1243():54-68. PubMed ID: 22211893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin, other antidiabetic drugs, and endometrial cancer risk: a nested case-control study within Italian healthcare utilization databases.
    Franchi M; Asciutto R; Nicotra F; Merlino L; La Vecchia C; Corrao G; Bosetti C
    Eur J Cancer Prev; 2017 May; 26(3):225-231. PubMed ID: 27222938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives of metformin use in endometrial cancer and other gynaecological malignancies.
    Barczyński B; Frąszczak K; Kotarski J
    J Drug Target; 2022 Apr; 30(4):359-367. PubMed ID: 34753372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between metformin therapy and risk of gynecological cancer in patients: Two meta-analyses.
    Wen Q; Zhao Z; Wen J; Zhou J; Wu J; Lei S; Miao Y
    Eur J Obstet Gynecol Reprod Biol; 2019 Jun; 237():33-41. PubMed ID: 31009857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.